Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00896792 · ClinicalTrials.gov registry record · Early Phase 1
Nurse Practitioner Hospice Program for Patients With Terminal Metastatic Cancer and Their Families or Caregivers
A Early Phase 1 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 26
- Enrollment target
NCT00896792: Completed Early Phase 1 study, sponsored by Mayo Clinic.
NCT00896792 is a Early Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 26 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (51% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00896792, a Early Phase 1 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 26 participants
- Enrollment target
Study Summary
RATIONALE: Gathering information about patients with terminal metastatic cancer may help doctors learn more about the effectiveness of a nurse practitioner hospice program. It is not yet known whether a nurse practitioner program helps increase patients' length of stay in hospice. PURPOSE: This randomized research study is evaluating a nurse practitioner hospice program for patients with terminal metastatic cancer and their families or caregivers.
Interventions
- OTHER questionnaire administration
- OTHER survey administration
- OTHER counseling intervention
- PROCEDURE psychosocial assessment and care
- PROCEDURE end-of-life treatment/management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2008-10-10 |
| Est. Completion | 2015-03-17 |
| Phase | Early Phase 1 |
What the finished NCT00896792 record still lists
NCT00896792 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (51% lower).
The record links to 0 conditions, and to 5 interventions - of which questionnaire administration is the first listed.
NCT00896792 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00896792 about?
NCT00896792 is a clinical study titled "Nurse Practitioner Hospice Program for Patients With Terminal Metastatic Cancer and Their Families or Caregivers". RATIONALE: Gathering information about patients with terminal metastatic cancer may help doctors learn more about the effectiveness of a nurse practitioner hospice program. It is not yet known whether a nurse practitioner program helps increase patients' length of stay in hospice. PURPOSE: This ran...
What is the current status of trial NCT00896792?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 26 participants. The study started on 2008-10-10. Estimated completion is 2015-03-17.
What interventions are being tested in trial NCT00896792?
The interventions under investigation include: questionnaire administration (OTHER), survey administration (OTHER), counseling intervention (OTHER), psychosocial assessment and care (PROCEDURE), end-of-life treatment/management (PROCEDURE).
Who is sponsoring clinical trial NCT00896792?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00896792's enrollment target sits among peer trials
26 977th of 2000 higher than 1,001 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI